Archive for the ‘taylor and francis’ Category
In this case, it’s easy to see how editors were duped (as it were). Both journals received the papers within a few months of each other, and then published them in quick succession; both have since been retracted. The papers share a first author, Jin Li, affiliated with Jiujiang University in China.
How similar are Li’s papers? See for yourself.
Here’s the abstract for “Landesman-Lazer type condition for second-order differential equations at resonance with impulsive effects,” received by Advances in Difference Equations in June 2014 and published in September 2014: Read the rest of this entry »
That brings Zaman’s total to 20, and ties him at the #18 spot on our leaderboard.
One of the more recently discovered retractions is for fake peer review, attributed to Zaman; one is for plagiarism, and two other papers were withdrawn while in press, for reasons that are unclear. (Note bene: These retractions are all at least one year old.)
First, the retraction notice for peer review issues, published in April 2015 for “Environmental Indicators and Energy Outcomes: Evidence from World Bank’s Classification Countries:”
The Journal of Sex & Marital Therapy has retracted a 2012 paper by a pair of authors in Spain who failed to obtain approval to adapt the model of sexual function they used in their study.
The article indicates that the work was based on previous research. But that declaration wasn’t enough to satisfy the creators of the model involved.
A journal has retracted a paper on a controversial course of treatment used to stunt the growth of disabled children, at the request of the human research ethics committee at the University of Waikato in New Zealand.
The paper described the so-called Ashley Treatment — explored last week in the New York Times — in which disabled children receive hormones and procedures to keep them small and diminish the effects of puberty, making it easier for them to be cared for. The retracted paper analyzed the use of the treatment in a girl named Charley who was born in New Zealand with a brain injury, whose case has attracted the attention of The Washington Post and People magazine, among other outlets.
The paper analyzed Charley’s case, and did not involve any clinical subjects. But the retraction note suggests that the ethics of publishing this paper weren’t fully worked out:
The article, “A novel method of feature extraction and fusion and its application in satellite images classification,” purportedly was written by Da Lin and Xin Xu, of Wuhan University. But as the retraction notice makes clear, that wasn’t the case: Read the rest of this entry »
An article describing a Japanese imaging device that measures eye surface temperature to help diagnose ocular conditions has been retracted because it contained duplicated material that the authors had published previously in German.
Here’s the September retraction note for “Measurement of Dynamic Ocular Surface Temperature in Healthy Subjects Using a New Thermography Device,” published in the journal Current Eye Research in 2012: Read the rest of this entry »
The Office of Research Integrity’s findings are based on an inquiry at Virginia Commonwealth University, where Girija Dasmahapatra worked until July of this year, investigating possible therapies for cancer. The misconduct affected research funded by three grants from the National Institutes of Health. Steven Grant, a researcher at VCU, is the principal investigator on the grants, each of which total over $2 million in funding. All of the 11 affected papers will be corrected or retracted, according to the ORI notice.
Two of the papers containing “falsified and/or fabricated” data — a study on an experimental combination of drugs for blood cancer and one on chemotherapies for rare forms of lymphoma — were covered in press releases by VCU.
According to the notice in the Federal Register:
In August, we reported on a clinical trial on hundreds of hypertensive patients that was published six times. Now, copies published in Expert Opinion on Drug Safety and Journal of the American Society of Hypertension (JASH) have been retracted, making for a total of three retractions for the group of papers.
The authors have defended the papers as being decidedly “different,” but one of the latest retraction notes points to an earlier retraction by some of the same authors (including first author Giuseppe Derosa, at the University of Pavia in Italy) for publishing two papers that “contain considerable text that is duplicative.”
Inflammation editor in chief Bruce Cronstein, who retracted one of the six duplicated papers from the clinical trial, told us in August that he and the editors of the other journals were all contacted “en masse” by an author doing a Cochrane Review on hypertension, who noticed that all six papers were “nearly identical.”
Just recently, we received a statement from the authors — sent by corresponding author Derosa — which argued that even if six papers stem from one trial, each was decidedly “different:”
Plant researcher Jaime A. Teixeira da Silva has been banned from submitting papers to any journals published by Taylor & Francis. The reason: “continuing challenges” to their procedures and the use of “inflammatory language.”
This is the second time Teixeira da Silva has been banned by a publisher — last year Elsevier journal Scientia Horticulturae told him that they refused to review his papers following “personal attacks and threats.”
Apparently, Taylor & Francis has too become frustrated with Teixeira da Silva’s communication strategy. Anthony Trioli, from Taylor & Francis, told Teixeira da Silva in an email (to which Teixeira da Silva copied us on his reply) that they would no longer accept his papers:
The “accepted author version” was published online in June, in Plant Signaling & Behavior. But before the so-called “version of record” could make it into an official issue of the journal — which is online-only — it was retracted.